Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: PATIENTS HAVING ANY ONE OF THE CLINICAL SIGNS AND SYMPTOMS OF BRONCHIAL ASTHMA DYSPNEA H/O WITH OR WITHOUT WHEEZING WILLING TO GIVE SPECIMEN FOR BLOOD INVESTIGATION WHEN REQUIRED WILLING TO GIVE WRITTEN CONSENT TO PARTICIPATE IN STUDY
Exclusion criteria
Exclusion criteria: PREGNANCY AND LACTATION MOTHER DIABETIC MELLITUS SEVERE ASTHMATIC CONDITION CONGESTIVE CARDIAC FAILURE,BRONCHIECTASIS BRONCHOGENIC CARCINOMA PULMONARY TB CHRONIC BRONCHITIS STATUS ASTHMATICUS ANY OTHER SERIOUS SYSTEMIC ILLNESS PATIENT WILL BE EXCLUDED CLINICALLY OR BASED ON AVAILABLE MEDICAL REPORTS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OUTCOME WILL BE ASSESSED ON EVERY VISIT OF THE PATIENT BY REDUCTION IN CLINICAL SYMPTOMS PEFR ABSOLUTE EOSINOPHIL COUNTTimepoint: OUTCOME WILL BE ASSESSED ON EVERY VISIT OF THE PATIENT BY REDUCTION IN CLINICAL SYMPTOMS PEFR ABSOLUTE EOSINOPHIL COUNT FOR 48 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| OUTCOME WILL BE ASSESSED ON EVERY VISIT OF THE PATIENT BY REDUCTION IN CLINICAL SYMPTOMS PEFR ABSOLUTE EOSINOPHIL COUNTTimepoint: 48 DAYS | — |
Countries
India
Contacts
GOVERNMENT SIDDHA MEDICAL COLLEGE,CHENNAI